in the illness, whereas other areas preserve features now current in different stages of B-cell differentiation. Evaluation on the CLL microenvironment has delivered clues to grasp the survival of tumor cells and resistance to therapy. All this information has provided new perspectives that are now being exploited therapeutically with novel brokers